Perhaps consider researching PTX-200 and CellPryme-A. PTX's pipeline (shelved and/or repurposed) has real promise in the space of pancreatic cancer, Scotty, and not just PTX-100. Here's a summary from Grok on PTX-200 and pancreatic cancer:-
The following is the summary of pre-clinical results carried out already:
PTX Price at posting:
4.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)